STE Quote, Financials, Valuation and Earnings

Intuitive Surgical has a net margin of 9.84% compared to Steris PLC's net margin of 30.99%. Steris PLC's return on equity of 9.5% beat Intuitive Surgical's return on equity of 15.82%.

Steris PLC has a consensus price target of $256.86, signalling upside risk potential of 2.1%. On the other hand Intuitive Surgical has an analysts' consensus of $573.63 which suggests that it could grow by 1.78%. Given that Steris PLC has higher upside potential than Intuitive Surgical, analysts believe Steris PLC is more attractive than Intuitive Surgical.

Steris PLC has a beta of 0.956, which suggesting that the stock is 4.397% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.697, suggesting its more volatile than the S&P 500 by 69.708%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.89%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.5B, which are smaller than Intuitive Surgical quarterly revenues of $2.3B. Steris PLC's net income of $145.7M is lower than Intuitive Surgical's net income of $698.4M. Notably, Steris PLC's price-to-earnings ratio is 40.58x while Intuitive Surgical's PE ratio is 82.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.57x versus 23.48x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

INVO Fertility has a net margin of 9.84% compared to Steris PLC's net margin of --. Steris PLC's return on equity of 9.5% beat INVO Fertility's return on equity of --.

Steris PLC has a consensus price target of $256.86, signalling upside risk potential of 2.1%. On the other hand INVO Fertility has an analysts' consensus of -- which suggests that it could grow by 201.51%. Given that INVO Fertility has higher upside potential than Steris PLC, analysts believe INVO Fertility is more attractive than Steris PLC.

Steris PLC has a beta of 0.956, which suggesting that the stock is 4.397% less volatile than S&P 500. In comparison INVO Fertility has a beta of 2.243, suggesting its more volatile than the S&P 500 by 124.267%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.89%. INVO Fertility offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. INVO Fertility pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.5B, which are larger than INVO Fertility quarterly revenues of --. Steris PLC's net income of $145.7M is higher than INVO Fertility's net income of --. Notably, Steris PLC's price-to-earnings ratio is 40.58x while INVO Fertility's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.57x versus 0.10x for INVO Fertility. Usually stocks with elevated PS ratios are considered overvalued.

Nutriband has a net margin of 9.84% compared to Steris PLC's net margin of -211%. Steris PLC's return on equity of 9.5% beat Nutriband's return on equity of -69.58%.

Steris PLC has a consensus price target of $256.86, signalling upside risk potential of 2.1%. On the other hand Nutriband has an analysts' consensus of $13.00 which suggests that it could grow by 131.32%. Given that Nutriband has higher upside potential than Steris PLC, analysts believe Nutriband is more attractive than Steris PLC.

Steris PLC has a beta of 0.956, which suggesting that the stock is 4.397% less volatile than S&P 500. In comparison Nutriband has a beta of 1.185, suggesting its more volatile than the S&P 500 by 18.545%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.89%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.5B, which are larger than Nutriband quarterly revenues of $645.8K. Steris PLC's net income of $145.7M is higher than Nutriband's net income of -$1.4M. Notably, Steris PLC's price-to-earnings ratio is 40.58x while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.57x versus 27.86x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

Zimmer Biomet Holdings has a net margin of 9.84% compared to Steris PLC's net margin of 9.53%. Steris PLC's return on equity of 9.5% beat Zimmer Biomet Holdings's return on equity of 7.29%.

Steris PLC has a consensus price target of $256.86, signalling upside risk potential of 2.1%. On the other hand Zimmer Biomet Holdings has an analysts' consensus of $108.62 which suggests that it could grow by 12.29%. Given that Zimmer Biomet Holdings has higher upside potential than Steris PLC, analysts believe Zimmer Biomet Holdings is more attractive than Steris PLC.

Steris PLC has a beta of 0.956, which suggesting that the stock is 4.397% less volatile than S&P 500. In comparison Zimmer Biomet Holdings has a beta of 0.780, suggesting its less volatile than the S&P 500 by 21.988%.

Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.89%. Zimmer Biomet Holdings offers a yield of 0.99% to investors and pays a quarterly dividend of $0.24 per share. Steris PLC pays 35.77% of its earnings as a dividend. Zimmer Biomet Holdings pays out 21.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Steris PLC quarterly revenues are $1.5B, which are smaller than Zimmer Biomet Holdings quarterly revenues of $1.9B. Steris PLC's net income of $145.7M is lower than Zimmer Biomet Holdings's net income of $182M. Notably, Steris PLC's price-to-earnings ratio is 40.58x while Zimmer Biomet Holdings's PE ratio is 21.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.57x versus 2.54x for Zimmer Biomet Holdings. Usually stocks with elevated PS ratios are considered overvalued.